EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial intelligence in atrial fibrillation: emerging applications, research directions and ethical considerations

Ibrahim Antoun, Ahmed Abdelrazik, Mahmoud Eldesouky, Xin Li, Georgia R Layton, Mustafa Zakkar, Riyaz Somani, G André Ng

Frontiers in Cardiovascular Medicine · 24.06.2025 · 12

DOI: 10.3389/fcvm.2025.1596574 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 24.06.2025. Verfasst von Ibrahim Antoun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) is the most prevalent sustained arrhythmia and a major contributor to stroke and heart failure. Despite progress in management, challenges persist in early detection, risk stratification, and personalised treatment. Artificial intelligence (AI), especially machine learning (ML) and deep learning (DL), has emerged as a transformative tool in AF care. This scoping review examines the applications of AI across key domains: detection, risk prediction, treatment optimisation, and remote monitoring. AI-driven models enhance AF detection by analysing ECGs and wearable device data with high accuracy, enabling early identification of asymptomatic cases. By incorporating diverse clinical, imaging, and genomic data, predictive models outperform conventional risk scores in estimating stroke risk and disease progression. In treatment, AI assists in personalised anticoagulation decisions, catheter ablation planning, and optimising antiarrhythmic drug selection. Furthermore, AI-powered remote monitoring integrates wearable-derived insights with real-time decision support, improving patient engagement and adherence. Despite these advances, significant challenges persist, including algorithm transparency, bias, data integration, and regulatory hurdles. Explainable AI (XAI) is crucial to ensure clinician trust and facilitate implementation into clinical workflows. Future research should focus on large-scale validation, multi-modal data integration, and real-world AI deployment in AF management. AI has the potential to revolutionise AF care, shifting from reactive treatment to proactive, personalised management. Addressing current limitations through interdisciplinary collaboration will be key to realising AI's full potential in clinical practice and improving patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

ECGartificial intelligenceatrial fibrillationmachine learningpersonalised medicineremote monitoringrisk stratification

Autor:innen und Institutionen

  • Department of Cardiology, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
  • Department of Cardiovascular Sciences, Clinical Science Wing, Glenfield Hospital, University of Leicester, Leicester, United Kingdom.
  • Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
  • Department of Research, National Institute for Health Research Leicester Research Biomedical Centre, Leicester, United Kingdom.
  • Leicester British Heart Foundation Centre of Research Excellence, Glenfield Hospital, Leicester, United Kingdom.

Zitieren

APA

Antoun, I., Abdelrazik, A., Eldesouky, M., Li, X., Layton, G. R., Zakkar, M., Somani, R., & Ng, G. A. (2025). Artificial intelligence in atrial fibrillation: emerging applications, research directions and ethical considerations. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1596574

Vancouver

Antoun I, Abdelrazik A, Eldesouky M, Li X, Layton GR, Zakkar M, et al. Artificial intelligence in atrial fibrillation: emerging applications, research directions and ethical considerations. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1596574

BibTeX
@article{Antoun2025,
  author = {Antoun, Ibrahim and Abdelrazik, Ahmed and Eldesouky, Mahmoud and Li, Xin and Layton, Georgia R and Zakkar, Mustafa and Somani, Riyaz and Ng, G André},
  title = {Artificial intelligence in atrial fibrillation: emerging applications, research directions and ethical considerations},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fcvm.2025.1596574}
}
Kostenlos starten →